Biomarker Insights

Stephen F Kingsmore is President and CEO of the National Center for Genome Resources, Santa Fe, NM. NCGR is an independent, non-profit, bioinformatics research institute, focused on improving human health and nutrition by translating bioscience research with computing and math. Dr Kingsmore's current research is focused on the development of biomarkers to predict outcomes in infectious diseases. Previously, Dr. Kingsmore was in senior management positions in two biotechnology companies developing novel technologies for drug discovery and development: From 1999-2004, he was Chief Operating Officer of Molecular Staging Inc., New Haven, CT and Vice President of Research of CuraGen Corporation, New Haven, CT.

Before that, Dr Kingsmore was an Assistant Professor at the University of Florida in Gainesville, where he positionally cloned 5 disease genes. He has published over 75 peer-reviewed research papers on clinical biomarker development, and disease gene identification. Dr. Kingsmore received a B.S. in medical microbiology from the Queen's University of Belfast with first class honors in 1982 and graduated in medicine (M.B., Ch.B., B.A.O.) from the same institution in 1985. He completed internship and residency in Internal Medicine, and a fellowship in Rheumatology, at Duke University Medical Center, Durham, NC, USA.

>> Dr Kingsmore's latest call for papers